This hypothesis proposes that astrocytic NLRP3 inflammasome activation in neuroinflammation can be attenuated through enhancement of bulk autophagy flux rather than selective mitophagy. In astrocytes, NLRP3 activation is triggered by accumulation of misfolded protein aggregates and damaged organelles that overwhelm the cellular quality control systems. The mechanistic foundation centers on the observation that impaired autophagosome-lysosome fusion creates a bottleneck in autophagy flux, leading to cytoplasmic accumulation of p62/SQSTM1-positive protein aggregates. These aggregates serve as scaffolding platforms that facilitate NLRP3 oligomerization and inflammasome assembly through direct protein-protein interactions between p62 and NLRP3. Enhancement of autophagy flux through pharmacological activation of transcription factor EB (TFEB) or mechanistic target of rapamycin (mTOR) inhibition would accelerate clearance of these aggregated proteins, thereby reducing available nucleation sites for NLRP3 assembly.

This hypothesis proposes that astrocytic NLRP3 inflammasome activation in neuroinflammation can be attenuated through enhancement of bulk autophagy flux rather than selective mitophagy. In astrocytes, NLRP3 activation is triggered by accumulation of misfolded protein aggregates and damaged organelles that overwhelm the cellular quality control systems. The mechanistic foundation centers on the observation that impaired autophagosome-lysosome fusion creates a bottleneck in autophagy flux, leading to cytoplasmic accumulation of p62/SQSTM1-positive protein aggregates. These aggregates serve as scaffolding platforms that facilitate NLRP3 oligomerization and inflammasome assembly through direct protein-protein interactions between p62 and NLRP3. Enhancement of autophagy flux through pharmacological activation of transcription factor EB (TFEB) or mechanistic target of rapamycin (mTOR) inhibition would accelerate clearance of these aggregated proteins, thereby reducing available nucleation sites for NLRP3 assembly. Additionally, improved autophagy flux would enhance clearance of damaged mitochondria through general autophagy mechanisms, reducing mitochondrial ROS production and mtDNA release that otherwise serve as NLRP3 activation signals. The intervention targets astrocytes specifically because these cells exhibit heightened sensitivity to protein aggregate accumulation and serve as primary coordinators of neuroinflammatory responses through extensive communication with microglia via cytokine signaling. Astrocytic IL-1β and IL-18 secretion following NLRP3 activation creates paracrine inflammatory cascades that amplify microglial activation and recruit peripheral immune cells. By interrupting this astrocyte-driven inflammatory amplification through autophagy enhancement, the hypothesis predicts reduced overall neuroinflammation and preservation of neuronal function in neurodegenerative diseases.